doi:10.1001/jama.2024.1014SARS-CoV-2This Medical News story discusses a recent study that found people who are immunocompromised clear SARS-CoV-2 at varying rates.Rubin, RitaJAMA: Journal of the American Medical Association
The ability of green bonds to provide returns for investors while lowering carbon dioxide emissions and funding environmental conservation initiatives is one of their benefits. Yet, it is crucial to assess the risk of holding a portfolio of green bonds in light of the current scenario (Gao et ...
Coronavirus disease 2019 (COVID-19) is caused by the novel severe acute respiratory coronavirus-2 (SARS-CoV-2). Several explanations for the development of cardiovascular complications during and after acute COVID-19 infection have been hypothe...
Short-term repeated SARS-CoV-2 passaging in immune-nave mice leads to the virus acquiring lineage-specific differences in antibody resistance, interferon suppression and infection phenotypes.Communications Biology